# US 2013/0157969 A1 · Polyol modified aminoglycoside-lipid conjugates

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157969 A1
- Document ID: US20130157969A1
- Status: Published application
- Kind: A1
- Application number: 13/639,223
- Filed: 2011-04-05
- Published: 2013-06-20
- Earliest claimed: 2010-04-06
- Assignees: University of Manitoba
- Inventors: Frank Schweizer; Smritilekha Bera; George Zhanel
- Web page: https://patentgrep.com/patent/US20130157969A1

## CPC

- C07H 15/224: with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
- A61P 31/04: Antibacterial agents
- C07H 17/04: Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

In some aspects, the present invention provides aminoglycoside derivatives thereof that exhibit antibacterial activity. In some aspects, the aminoglycoside derivatives comprise compounds consisting of (a) an ammoglycoside group and (b) at least one hydrophobic carbamate and alkoxy group to the primary or secondary hydroxy position of the aminolvcoside group and salts thereof. Additionally, methods of treating and preventing bacterial infections using the aminoglycoside derivatives are also provided

## Claims

### Claim at position 1

1-32. (canceled)

### Claim 33

An aminoglycoside derivative comprising:
(a) an aminoglycoside group; and
(b) at least one carbamate group or alkoxy group attached to a primary or secondary hydroxy position of the aminoglycoside group;
or a salt thereof.

### Claim 34 (depends on 33)

The aminoglycoside derivative of claim 33, wherein the aminoglycoside is further defined as an aminoglycoside antibiotic.

### Claim 35 (depends on 34)

The aminoglycoside derivative of claim 34, wherein the aminoglycoside antibiotic is selected from the group consisting of a neomycin, a kanamycin, paromomycin, amikacin, neamine, a gentamicin, netilmycin, a streptomycin, tobramycin, a hygromycin, sisomycin and a spectinomycin.

### Claim 36 (depends on 33)

The aminoglycoside derivative of claim 33, wherein the aminoglycoside derivative is present as a trifluoroacetic acid salt.

### Claim 37

An aminoglycoside derivative defined as:
wherein
each R1 and each R2 are each independently:
H, C(NH)NH2, —C(O)(NH2), alkyl(C≦18), alkenyl(C≦18), aryl(C≦18), aralkyl(C≦18), heteroaryl(C≦18), heteroaralkyl(C≦18), acyl(C≦18), or substituted versions thereof, provided that not all R1 and R2 are H;
or pharmaceutically-acceptable salts thereof.

### Claim 38 (depends on 37)

The aminoglycoside derivative of claim 37, wherein R1 is H; and R2 is C(O)NHC6H5, C(O)NH-p-C6H4Cl, C(O)NHC6H13, C(O)NH-p-C6H4N(Me)2, CH2C6H5, CH2-p-C6H4Cl, CH2-p-C6H4C(CH3)4, or CH3.

### Claim 39 (depends on 38)

The aminoglycoside derivative of claim 38, wherein R2 is C(O)NHC6H5.

### Claim 40 (depends on 38)

The aminoglycoside derivative of claim 38, wherein R2 is CH2C6H5.

### Claim 41

An aminoglycoside derivative defined as:
wherein
each R1 and each R2 are each independently:
H, C(NH)NH2, C(O)(NH2), alkyl(C≦18), alkenyl(C≦18), alkynyl(C≦18), aryl(C≦18), aralkyl(C≦18), heteroaryl(C≦18), heteroaralkyl(C≦18), acyl(C≦18), or substituted versions thereof, provided that not all R1 and R2 are H;
or pharmaceutically-acceptable salts thereof.

### Claim 42 (depends on 41)

The aminoglycoside derivative of claim 41, wherein R1 is H; and R2 is C(O)NHC6H5, C(O)NHC6H13, —C(O)NH-p-C6H4N(Me)2, CH2C6H5, CH2-p-C6H4Cl, or CH3.

### Claim 43

An aminoglycoside derivative defined as:
wherein
each R1 is H, —C(NH)NH2, —C(O)(NH2), alkyl(C≦18), alkynyl(C≦18), aralkyl(C≦18), heteroaryl(C≦18), heteroaralkyl(C≦18), acyl(C≦18), or substituted versions thereof;
or pharmaceutically-acceptable salts thereof.

### Claim 44 (depends on 43)

The aminoglycoside derivative of claim 43, wherein R1 is H.

### Claim 45

An aminoglycoside derivative defined as:
wherein
each R1 and each R2 are each independently:
H, C(NH)NH2, —C(O)(NH2), alkyl(C≦18), alkenyl(C≦18), alkynyl(C≦18), aryl(C≦18), aralkyl(C≦18), heteroaryl(C≦18), heteroaralkyl(C≦18), acyl(C≦18), or substituted versions thereof, provided that not all R1 and R2 are H;
or pharmaceutically-acceptable salts thereof.

### Claim 46 (depends on 45)

The aminoglycoside derivative of claim 45, wherein R1 is H; and R2 is C(O)NHC6H5, C(O)NHC6H13, CH2C6H5, CH2-p-C6H4Cl, or CH3.

### Claim 47 (depends on 46)

The aminoglycoside derivative of claim 46, wherein R2 is C(O)NHC6H13.

### Claim 48 (depends on 33)

A pharmaceutical composition comprising an aminoglycoside derivative of claim 33.

### Claim 49 (depends on 33, 48)

The pharmaceutical composition of claim 48, wherein the aminoglycoside derivative is further defined as the aminoglycoside derivative of claim 33.

### Claim 50 (depends on 37, 48)

The pharmaceutical composition of claim 48, wherein the aminoglycoside derivative is further defined as the aminoglycoside derivative of claim 37.

### Claim 51 (depends on 41, 48)

The pharmaceutical composition of claim 48, wherein the aminoglycoside derivative is further defined as the aminoglycoside derivative of claim 41.

### Claim 52 (depends on 45, 48)

The pharmaceutical composition of claim 48, wherein the aminoglycoside derivative is further defined as the aminoglycoside derivative of claim 45.

### Claim 53 (depends on 33)

A method of treating or preventing a bacterial infection in a subject comprising administering to the subject an effective amount of an aminoglycoside antibiotic derivative of claim 33.

### Claim 54 (depends on 33, 53)

The method of claim 53, wherein the aminoglycoside antibiotic derivative is further defined as the aminoglycoside derivative of claim 33.

### Claim 55 (depends on 37, 53)

The method of claim 53, wherein the aminoglycoside antibiotic derivative is further defined as the aminoglycoside derivative of claim 37.

### Claim 56 (depends on 41, 53)

The method of claim 53, wherein the aminoglycoside antibiotic derivative is further defined as the aminoglycoside derivative of claim 41.

### Claim 57 (depends on 45, 53)

The method of claim 53, wherein the aminoglycoside antibiotic derivative is further defined as the aminoglycoside derivative of claim 45.

### Claim at position 27

58-73. (canceled)
